Response to Dai et al

Affiliations

¹ 1] Department of Gastroenterology, University Hospital of Bicêtre, Assistance Publique Hôpitaux de Paris, Université Paris-Sud, Le Kremlin Bicêtre, France [2] INSERM, UMRS 1018, Team 9, Centre for Research in Epidemiology and Population Health, Université Paris-Sud, Institut Gustave Roussy, Villejuif, France.
² INSERM, UMRS 1018, Team 9, Centre for Research in Epidemiology and Population Health, Université Paris-Sud, Institut Gustave Roussy, Villejuif, France.

Comment

Antoine Racine et al. Am J Gastroenterol. 2014 Sep.

. 2014 Sep;109(9):1494-5.

doi: 10.1038/ajg.2014.236.

¹ 1] Department of Gastroenterology, University Hospital of Bicêtre, Assistance Publique Hôpitaux de Paris, Université Paris-Sud, Le Kremlin Bicêtre, France [2] INSERM, UMRS 1018, Team 9, Centre for Research in Epidemiology and Population Health, Université Paris-Sud, Institut Gustave Roussy, Villejuif, France.
² INSERM, UMRS 1018, Team 9, Centre for Research in Epidemiology and Population Health, Université Paris-Sud, Institut Gustave Roussy, Villejuif, France.

No abstract available

Comment on

Isotretinoin and risk of inflammatory bowel disease: a French nationwide study.
Racine A, Cuerq A, Bijon A, Ricordeau P, Weill A, Allemand H, Chosidow O, Boutron-Ruault MC, Carbonnel F. Racine A, et al. Am J Gastroenterol. 2014 Apr;109(4):563-9. doi: 10.1038/ajg.2014.8. Epub 2014 Feb 18. Am J Gastroenterol. 2014. PMID: 24535094
Isotretinoin and risk of inflammatory bowel disease.
Dai C, Jiang M, Sun MJ. Dai C, et al. Am J Gastroenterol. 2014 Sep;109(9):1493-4. doi: 10.1038/ajg.2014.184. Am J Gastroenterol. 2014. PMID: 25196874 No abstract available.